TCTR20200526003已完成4 期
Role of lactulose for prophylaxis of hepatic encephalopathy in cirrhotic patients presenting with upper gastrointestinal bleeding
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- one
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •cirrhotic patients presenting with upper gastrointestinal bleeding who underwent esophagograstroduodenoscopy within 24 hours after symptom presentation.
排除标准
- •1. underlying disease of neurological disease
- •2. presence of hepatic encephalopathy at the time of admission
- •3. history of lactulose usage within 6 weeks before
- •4. severe co-morbidity such as acute kidney injury, active cardiopulmonary disease
- •5. history of alcohol ingestion within 7 days before
研究者
相似试验
Unknown
4 期
Primary Prophylaxis of Hepatic Encephalopathy in Patients With CirrhosisHepatic EncephalopathyNCT01175538Govind Ballabh Pant Hospital
Unknown
3 期
Lactulose for the Prevention of Hepatic Encephalopathy in Cirrhotic Patients With Upper Gastrointestinal HemorrhageHepatocerebral EncephalopathyPortal-Systemic EncephalopathyEncephalopathy, HepaticEncephalopathy, HepatocerebralNCT00553423Aga Khan University128
Unknown
不适用
Lactulose for the Prevention of Nosocomial Infections in ChildrenNosocomial InfectionNCT00273949Bnai Zion Medical Center100
已完成
2 期
Comparison Between Lactulose and Lactulose-Paraffin in Cirrhotic PatientsHepatic EncephalopathyCirrhosisNCT02017119Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran40
已完成
不适用
A Study of Controlled Lactulose WithdrawalHepatic EncephalopathyNCT00914056Hunter Holmes Mcguire Veteran Affairs Medical Center7